Pear Therapeutics, Inc.
PEAR · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26,371 | -$30,723 | $5,462 | -$23,859 |
| Dep. & Amort. | $1,533 | $1,473 | $1,400 | $1,296 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,683 | $3,563 | $3,386 | $2,901 |
| Change in WC | -$2,592 | -$1,005 | -$851 | -$5,315 |
| Other Non-Cash | -$533 | $3,422 | -$39,034 | -$11,731 |
| Operating Cash Flow | -$24,280 | -$23,270 | -$29,637 | -$36,708 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,070 | -$580 | -$1,319 | -$501 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$23,036 | -$42,999 | -$23,036 | -$42,999 |
| Inv. Sales/Matur. | $13,000 | $23,000 | $24,048 | $0 |
| Other Inv. Act. | $23,036 | $42,999 | $0 | $0 |
| Investing Cash Flow | $11,930 | $22,420 | -$307 | -$43,500 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,795 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $886 | $358 | $761 | $75 |
| Financing Cash Flow | $961 | $358 | $761 | $75 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$11,389 | -$492 | -$29,183 | -$80,133 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $60,170 | $60,662 | $89,845 | $169,978 |
| End Cash | $48,781 | $60,170 | $60,662 | $89,845 |
| Free Cash Flow | -$25,350 | -$23,850 | -$30,956 | -$37,209 |